MedPath

Histidine-Rich Glycoprotein as a novel severity biomarker for sepsis: application to early treatment

Not Applicable
Conditions
Sepsis
Registration Number
JPRN-UMIN000030037
Lead Sponsor
Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Brief Summary

Although there was no time x survivors/non-survivors interaction in the time courses of HRG (P=0.34), the main effect of generalized linear mixed models was significant (P<0.001). In a univariate Cox proportional hazards model with each variable as a time-dependent covariate, higher HRG levels were significantly associated with a lower risk of mortality (hazard ratio, 0.85 [95%CI, 0.78-0.92]; P<0.001).

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
201
Inclusion Criteria

Not provided

Exclusion Criteria

Pregnancy and Under 20 years old

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath